Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avidity Biosciences (RNA) Interest Expenses (2019 - 2020)

Avidity Biosciences (RNA) has disclosed Interest Expenses for 2 consecutive years, with $131000.0 as the latest value for Q2 2020.

  • For the quarter ending Q2 2020, Interest Expenses changed N/A year-over-year to $131000.0, compared with a TTM value of $131000.0 through Mar 2021, down 97.77%, and an annual FY2020 reading of $209000.0, down 97.17% over the prior year.
  • Interest Expenses was $131000.0 for Q2 2020 at Avidity Biosciences, up from $78000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $4.3 million in Q4 2019 and bottomed at $78000.0 in Q1 2020.